“…OAS1 was liable for progression of severe acute respiratory syndrome (SARS) viral infection [ Hamano et al, 2005 ], but this gene may be associated with development of SARS-CoV-2 infection. Enriched genes such as CCL4 [ Al-Afif et al, 2015 ], IFIT3 [ Ternette et al, 2011 ], CCR1 [ Miller et al, 2006 ], CXCL13 [ Chalin et al, 2018 ], CX3CR1 [ Anderson et al, 2020 ] and DUSP1 [ Robitaille et al, 2017 ] were associated with progression of respiratory syncytial virus infection, but these genes may be key for advancement of SARS-CoV-2 infection. The novel biomarkers (CARD16, MEFV (MEFV innate immunity regulator, pyrin), CYBB (cytochrome b -245 beta chain), GBP4, CARD6, CASP5, HLX (H2.0 like homeobox), IL2RA, IL2RG, IL18RAP, GZMB (granzyme B), UBE2L6, FCGR1B, TRIM38, EIF2AK2, TRIM34, KPNA5, WARS1, PIK3CG, PRKCB (protein kinase C beta), TIAM2, DOCK2, GNB4, PTPRC (protein tyrosine phosphatase receptor type C), POR (cytochrome p 450 oxidoreductase), SLC27A2, RPL21, RPL26, RPL27, RPL27A, RPL29, RPL31, RPL32, RPL34, RPL37, RPL39, RPL36A, RPLP0, RPLP1, RPLP2, RPS2, RPS3, RPS3A, RPS5, RPS7, RPS8, RPS9, RPS10, RPS14, RPS15, RPS15A, RPS16, RPS18, RPS21, RPS27, RPS28, RPS29, FAU (FAU ubiquitin like and ribosomal protein S30 fusion), RPL36, MRPL14, RPS10-NUDT3, RPL10A, RPL17-C18orf32, RPL35, RPL13A, RPL3, RPL6, RPL7, RPL7A, RPL8, RPL15, RPL19, FOS (Fos proto-oncogene, AP-1 transcription factor subunit), JUNB (JunB proto-oncogene, AP-1 transcription factor subunit), JUND (JunD proto-oncogene, AP-1 transcription factor subunit), RPS12, COX5A, UQCRC1, COX4I1, COX5B, COX6A1, COX7B, ATP5F1E, ATP6V0B, SLC25A6, SEPTIN5, UQCRQ (ubiquinol-cytochrome c reductase complex III subunit VII), CYC1, NDUFA2, NDUFA4, NDUFAB1, NDUFB2, NDUFB7, NDUFB10, NDUFC1, NDUFV1, NDUFS6, UQCR11, TUBB2A, TUBB4B, ARPC1A, ARF5, DNAI2, SSR4, PGLS (6-phosphogluconolactonase), TALDO1 and TKT (transketolase)) obtained from the pathway enrichment analysis are all may be associated in SARS-CoV-2 infection progression process, which suggesting that these novel biomarkers may serve as diagnostics biomarkers or therapeutic targets for this infection.…”